Evidence map›Paper›PMID 37064292›Full record

ArticleInternational journal of nanomedicine2023

Concurrent Tissue Engineering for Wound Healing in Diabetic Rats Utilizing Dual Actions of Green Synthesized CuO NPs Prepared from Two Plants Grown in Egypt.

Noha Khalifa Abo Aasy, Sarah A El-Lakany, Perusi M Masanga, Elbadawy A Kamoun, Shahira H El-Moslamy, Marwa Abu-Serie, Rania G Aly, Nazik A Elgindy

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Noha Khalifa Abo AasyDepartment of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.ORCID 0000-0003-4348-0318
Sarah A El-LakanyDepartment of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.ORCID 0000-0001-9725-782X
Perusi M MasangaSt John's University of Tanzania, Dodoma, Tanzania.
Elbadawy A KamounPolymeric Materials Research Department, Advanced Technology and New Materials Research Institute (ATNMRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Egypt.
Shahira H El-MoslamyBioprocess Development Department (BID), Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Alexandria, 21934, Egypt.ORCID 0000-0003-0836-1444
Marwa Abu-SerieMedical Biotechnology Department (MBD), Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-city), New Borg El-Arab City, Alexandria, 21934, Egypt.
Rania G AlyDepartment of Surgical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Nazik A ElgindyDepartment of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Alexandria University · EGCity of Scientific Research and Technological Applications · EGBritish University in Egypt · EGSt. John's University of Tanzania · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Diabetes mellitus is among the disrupting factors of orchestrated events in wound healing. This necessitates the urge for tailored medications, which are continually offered by nano-sized materials. Herein, we present greenly synthesized copper oxide nanoparticles (CuO NPs), obtained from either Methods: PG or GV plant extracts were compared as source of reducing agents for CuO NPs synthesis process. The yield and photocatalytic degradation potential were compared. NPs obtained from the superior extract, PG, were characterized using particles size, zeta potential, XRD, TEM, SEM, and EDX. The antimicrobial effects were evaluated on multidrug-resistant human pathogens and then the percentage biofilm inhibitory concentration was determined. The cytotoxicity and wound scratch study were conducted on a normal human skin cell line. In-vivo wound healing activity in diabetic rats was assessed along with histopathological and immunohistochemical examination of CD45 and α-SMA. Results: The greenly synthesized CuO NPs are spherical in shape having a diameter of 233nm. CuO NPs (250µg/mL) acted as promising biocontrol agent against a variety of multidrug-resistant human pathogens. They significantly exhibited 29.460±0.811% healing of the scratched wound compared to only 2.001±0.155% for the control. Wound healing experiments revealed the safety of a low CuO NPs concentration in a diabetic animal model as well as on human normal skin fibroblast cell line. The treated group with a dose of 2mg/cm Conclusion: Green synthesized CuO NPs could overcome drug resistance and promote wound healing process effectively.

Indexed as

Diabetes Mellitus, ExperimentalMetal NanoparticlesAnimalsCopperEgyptHumansPlant ExtractsRatsTissue EngineeringWound HealingCoppercupric oxidePlant Extractsbiofilm inhibitory concentrationcell compatibilitymetal ionplant extractionwound contraction

Identifiers

PMID37064292
PMCPMC10103783
OpenAlexW4363678799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.